Antipsychotic use in Australia: The patients' perspective

Australian and New Zealand Journal of Psychiatry

Volumn 36, Issue 5, 2002, Pages 633-641

  Castle, David ^a   Morgan, Vera ^a   Jablensky, Assen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antipsychotic; Atypical; Psychosis; Schizophrenia; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DRUG EFFICACY; DRUG USE; DYSPHAGIA; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MOTOR DYSFUNCTION; MUSCLE STIFFNESS; PATIENT ATTITUDE; POPULATION RESEARCH; PREVALENCE; PSYCHOSIS; RESTLESSNESS; SELF REPORT; TONGUE DISEASE; VISUAL DISORDER; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; AUSTRALIA; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 0036796163     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2002.01037.x     Document Type: Article

References (18)

1. Kane JM, Marder SR. Psychopharamcologic treatment of schizophrenia. Schizophrenia Bulletin 1993; 19:287-302.
2. Kane JM. Management issues in schizophrenia. London: Martin Dunitz, 2000.
3. Stahl SM. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. Journal of Clinical Psychiatry 1999; 60 (Suppl. 10):31-41.
4. Keks N, Altson K, Hope J et al. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Australian and New Zealand Journal of Psychiatry 1999; 33:896-901.
5. Callaly T, Trauer T. Patterns of use of antipsychotic medication in a regional community mental health service. Australasian Psychiatry 2000; 8:220-225.
6. Franz M, Lis S, Plüddemann K, Gallhofer B. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. British Journal of Psychiatry 1997; 170:422-425.
7. Naber D. Subjective experiences of schizophrenic patients treated with antipsychotic medication. International Clinical Psychopharmacology 1998; 13 (Suppl. 1):S41-S45.
8. Wasserman J, Criollo M. Subjective experiences of clozapine treatment by patients with chronic schizophrenia. Psychiatric Services 2000; 51:666-668.
9. Jablensky A, McGrath J, Herrman H et al. Psychotic disorders in urban areas. and overview of the study on low prevalence disorders. Australian and New Zealand Journal of Psychiatry 2000; 34:221-236.
10. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT diagnostic system. Archives of General Psychiatry 1991; 48:764-770.
11. Knol D, Berger M. Empirical comparison between factor analysis and multidimensional item response models. Multivariate Behavioral Research 1991; 26:457-477.
12. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 1997; 23:637-652.
13. Hansen TE. Casey DE, Hoffman WF. Neuroleptic intolerance. Schizophrenia Bulletin 1997; 23:567-582.
14. Gerlach J, Larsen EB. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica 1999; 99 (Suppl. 395):113-117.
15. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic review and meta-regression analysis. British Medical Journal 2001; 321:1371-1376.
16. Siris SG. Depression in schizophrenia. perspective in the era of 'atypical' antipsychotic agents. American Journal of Psychiatry 2000; 157:1379-1389.
17. Wang PS, West JC, Tanielian T, Pincus HA. Recent patterns and predictors of antipsychotic medication regimes used to treat schizophrenia and other psychotic disorders. Schizophrenia Bulletin 2000; 26:451-457.
18. Egan MF, Apud J, Wyatt RJ. Treatment of tardive dyskinesia. Schizophrenia Bulletin 1997; 23:583-610.